An Infant Who Suffered Seizures Many Times After Pentavalent Vaccination: A Case Report

Overview

Journal North Clin Istanb

Publisher Kare Publishing

Specialty General Medicine

Date 2020 Jun 2

PMID 32478306

Authors

Meryem Erat Nergiz

Hande Yetisgin

Alperen Aydin

Gulsum Iclal Bayhan

Aysegul Nese Citak Kurt

Affiliations

Soon will be listed here.

Abstract

Although rare, serious adverse effects may be seen after vaccination. Especially, the whole-cell pertussis vaccine has been held responsible for neurological side effects, as the most important problem in vaccination. With the advancement in vaccination technologies, whole-cell pertussis vaccine has been replaced by acellular pertussis vaccine, and neurological side effects have been significantly reduced. Herein, we present a 2-month-old male infant who suffered from generalized tonic-clonic seizures many times, possibly due to acellular pertussis after pentavalent vaccination, including diphtheria, acellular pertussis, tetanus, inactive polio, Haemophilus influenzae type B, and conjugate pneumococcal vaccine (BCG, DaBT-IPA-Hib, CPV).

References

Huang W, Gargiullo P, Broder K, Weintraub E, Iskander J, Klein N . Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010; 126(2):263-9. DOI: 10.1542/peds.2009-1496. View

Zangwill K, Eriksen E, Lee M, Lee J, Marcy S, Friedland L . A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Pediatrics. 2008; 122(6):e1179-85. DOI: 10.1542/peds.2008-1977. View

Berkovic S, Harkin L, McMahon J, Pelekanos J, Zuberi S, Wirrell E . De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol. 2006; 5(6):488-92. DOI: 10.1016/S1474-4422(06)70446-X. View

Braun M, Mootrey G, Salive M, Chen R, Ellenberg S . Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics. 2000; 106(4):E51. DOI: 10.1542/peds.106.4.e51. View

Korkmaz H, Aydin A, Unal B . Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy. Paediatr Int Child Health. 2014; 34(3):198-202. DOI: 10.1179/2046905513Y.0000000110. View

Geier D, Geier M . An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev. 2004; 26(5):296-300. DOI: 10.1016/S0387-7604(03)00169-4. View

Hansen J, Timbol J, Lewis N, Pool V, Decker M, Greenberg D . Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016; 34(35):4172-4179. DOI: 10.1016/j.vaccine.2016.06.062. View

Opri R, Zanoni G, Caffarelli C, Bottau P, Caimmi S, Crisafulli G . True and false contraindications to vaccines. Allergol Immunopathol (Madr). 2017; 46(1):99-104. DOI: 10.1016/j.aller.2017.02.003. View

Sun Y, Christensen J, Hviid A, Li J, Vedsted P, Olsen J . Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012; 307(8):823-31. DOI: 10.1001/jama.2012.165. View

10.

Nelson J, Yu O, Dominguez-Islas C, Cook A, Peterson D, Greene S . Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013; 177(2):131-41. DOI: 10.1093/aje/kws317. View